Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Lactoferricin inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine wounds

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Molecular characterization of Danish ESBL/AmpC-producing Klebsiella pneumoniae from bloodstream infections, 2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Detection of the optrA gene in a clinical ST16 Enterococcus faecalis isolate in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Adaptive Immune Response to Mycobacterium abscessus Complex (MABSC) in Cystic Fibrosis and the Implications of Cross-Reactivity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  5. Potential Advances of Adjunctive Hyperbaric Oxygen Therapy in Infective Endocarditis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

OBJECTIVES: Chronic wounds are characterised by prolonged inflammation, low mitogenic activity, high protease/low inhibitor activity, microbiota changes and biofilm formation, combined with the aetiology of the original insult. One strategy to promote healing is to terminate the parasitism-like relationship between the biofilm-growing pathogen and host response. Antimicrobial peptide AMC-109 is a potential treatment with low resistance potential and broad-spectrum coverage with rapid bactericidal effect. We aimed to investigate whether adjunctive AMC-109 could augment the ciprofloxacin effect in a chronic Pseudomonas aeruginosa wound model.

METHODS: Third-degree burns were inflicted on 33 BALB/c mice. Pseudomonas aeruginosa embedded in seaweed alginate was injected sub-eschar to mimic biofilm. Mice were randomised to receive AMC-109, combined AMC-109 and ciprofloxacin, ciprofloxacin, or placebo for 5 days followed by sample collection.

RESULTS: A lower bacterial load was seen in the double-treated group compared with either monotherapy group (AMC-109, p = 0.0076; ciprofloxacin, p = 0.0266). To evaluate the innate host response, cytokines and growth factors were quantified. The pro-inflammatory response was dampened in the double-treated mice compared with the mono-ciprofloxacin-treated group (p = 0.0009). Lower mobilisation of neutrophils from the bone marrow was indicated by reduced G-CSF in all treatment groups compared with placebo. Improved tissue remodelling was indicated by the highest level of tissue inhibitor of metalloproteases and low metalloprotease level in the double-treated group.

CONCLUSION: AMC-109 showed adjunctive antipseudomonal abilities augmenting the antimicrobial effect of ciprofloxacin in this wound model. The study indicates a potential role for AMC-109 in treating chronic wounds with complicating biofilm infections.

TidsskriftJournal of Global Antimicrobial Resistance
Sider (fra-til)185-193
Antal sider9
StatusUdgivet - 2022

Bibliografisk note

Copyright © 2021. Published by Elsevier Ltd.

ID: 72967017